French Registry: Late Gadolinium Enhancement in Hypertrophic Cardiomyopathy

Retrospective French Registry of Cardiovascular Magnetic Resonance Late Gadolinium Enhancement in Patients With Hypertrophic Cardiomyopathy

This study aims to create a registry of patients with hypertrophic cardiomyopathy, a condition characterized by excessive thickening of the heart muscle. This disease can sometimes lead to serious complications. Currently, the prognosis of these patients is mainly determined by clinical and echocardiographic parameters. Detection of myocardial fibrosis using cardiac MRI enables better risk stratification for these patients.

Inclusion Criteria:

1. Age ≥ 18 years
2. Ability to provide informed consent
3. HCM diagnosis referred for CMR assessment.

Exclusion Criteria:

1. Patients unable to provide informed consent,
2. Patients with a history of ischemic cardiomyopathy or myocarditis.